Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Jan 12;6(1):13-15.
doi: 10.46989/001c.92050. eCollection 2024.

Extramedullary myeloma progressed to plasmablastic myeloma

Ke Xu  1   2 , Charalampia Kyriakou  1
Affiliations
Case Reports

Extramedullary myeloma progressed to plasmablastic myeloma

Ke Xu et al. Clin Hematol Int. .
No abstract available

Keywords: Plasmablastic myeloma; extramedullary myeloma.

PubMed Disclaimer

Conflict of interest statement

Authors have no conflict of interest

Figures

Figure 1.
Figure 1.. (A) PET/CT at diagnosis; (B) PET/CT at first relapse; (C) PET/CT at second relapse; (D) Bone marrow aspirate at second relapse (May-Grünwald-Giemsa stain x100 objective).
See this image and copyright information in PMC

References

    1. Plasmablastic morphology-an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial e9486 report by the ECOG myeloma laboratory group. Greipp Philip R., Leong Traci, Bennett John M., Gaillard Jean P., Klein Bernard, Stewart James A., Oken Martin M., Kay Neil E., Van Ness Brian, Kyle Robert A. Apr 1;1998 Blood. 91(7):2501–2507. doi: 10.1182/blood.v91.7.2501. doi: 10.1182/blood.v91.7.2501. - DOI - DOI - PubMed
    1. Multiple myeloma: significance of plasmablastic subtype in morphological classification. Greipp P R, Raymond N M, Kyle R A, O'Fallon W M. Feb 1;1985 Blood. 65(2):305–310. doi: 10.1182/blood.v65.2.305.305. doi: 10.1182/blood.v65.2.305.305. - DOI - DOI - PubMed
    1. A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma. Giesen Nicola, Chatterjee Manik, Scheid Christof, Poos Alexandra M., Besemer Britta, Miah Kaya, Benner Axel, Becker Nicole, Moehler Thomas, Metzler Ivana, Khandanpour Cyrus, Seidel-Glaetzer Andrea, Trautmann-Grill Karolin, Kortüm K. Martin, Müller-Tidow Carsten, Mechtersheimer Gunhild, Goeppert Benjamin, Stenzinger Albrecht, Weinhold Niels, Goldschmidt Hartmut, Weisel Katja, Raab Marc S. Apr 6;2023 Blood. 141(14):1685–1690. doi: 10.1182/blood.2022017789. doi: 10.1182/blood.2022017789. - DOI - DOI - PubMed

Publication types

LinkOut - more resources